FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to dermatology and concerns method of dermatosis development prediction in women with scleropolycystic ovarian syndrome (SPCO). Method consists in venous blood analysis for leptine level on 3-5th day of independent or induced menstrual cycle. If At leptine level is 12.6 ng/ml and higher, acneiform rash and facial and scalp seborrhea oleosa are predicted.
EFFECT: enabled early prediction of dermatosis development in SPCO women.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ESTIMATING DEGREE OF SEVERITY OF OVARIAN DYSFUNCTION IN GIRLS WITH PUBERAL HYPERANDROGENISM | 2018 |
|
RU2690502C1 |
| METHOD OF DIAGNOSTICS OF MENSTRUAL DYSFUNCTION AGAINST BACKGROUND OF POLYCYSTIC OVARIAN SYNDROME BY IMMATURE GIRLS | 2013 |
|
RU2535096C1 |
| DIAGNOSTIC TECHNIQUE FOR HYPERANDROGENISM SYNDROME IN WOMEN OF REPRODUCTIVE AGE | 2010 |
|
RU2461354C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF OVARIAN AND ADRENAL HYPERANDROGENISM IN GIRLS OF PUBERTY AGE | 2015 |
|
RU2592235C1 |
| METHOD FOR TREATMENT OF POLYCYSTIC OVARY SYNDROME | 2017 |
|
RU2665969C1 |
| METHOD OF TREATMENT OF WOMEN WITH ACNE DISEASE | 1998 |
|
RU2148994C1 |
| DIAGNOSTIC TECHNIQUE FOR POLYCYSTIC OVARIAN SYNDROME IN ADOLESCENTS BY MEASURING URINE 2-OHE1/16α-OHE1 RATIO | 2014 |
|
RU2574020C1 |
| METHOD FOR PREDICTION OF DEGREE OF RISK OF POLYCYSTIC OVARIAN SYNDROME FORMATION IN ADOLESCENT GIRLS | 2016 |
|
RU2629720C1 |
| METHOD FOR TREATING STERILITY CAUSED BY HYPERANDROGENY AND HYPERPROLACTINEMIA | 2003 |
|
RU2237491C1 |
| METHOD FOR TREATING CHRONIC ANOVULATION AND PREVENTING SYNDROME OF OVARIAN HYPERSTIMULATION | 1999 |
|
RU2201225C2 |
